Efforts by US-based biopharmaceutical services provider Quintiles to reach out through digital channels to patients or other stakeholders, and to encourage participation in clinical trials, have reaped a clutch of awards for creative ingenuity and high-quality health resources.

Two videos from the company’s ClinicalResearch.com website, which features information and perspectives on clinical studies for and from patients, caregivers, healthy volunteers and healthcare professionals, as well as a global database of ongoing trials searchable by location and condition, have received International Davey Awards for creative excellence.

In addition, Quintiles’ corporate Facebook page was awarded a merit prize at the recent Web Health Awards organised by the US-based Health Information Resource Center.

The gold and silver Davey awards were for patient-community content from ClinicalResearch.com focusing on Alzheimer’s disease and arthritis respectively. Both videos were produced by US agency Contrast Creative. The International Davey awards are exclusively for small agencies and are judged by the International Academy of the Visual Arts.

Quintiles was recognised at the Web Health Awards for its corporate Facebook presence, which includes a variety of content for users ranging from customers and patients to employees and job seekers, as well as links to the clinical trials database and other materials on ClinicalResearch.com.

80% comeback

“While we know that less than 10% of the general population has ever been approached about participating in clinical research, we also know that more than 80% of those who have participated in trials say they would likely do it again,” commented David Coman, Quintiles’ senior vice president, communications and patient recruitment.

“This recognition of Quintiles’ efforts to connect with patients is independent confirmation that we’re on the right path,” Coleman added.

According to the company, ClinicalResearch.com has more than 165,000 registered users and has matched over 85,000 patients to clinical trial opportunities since its launch in September 2009.